10-Q Filing

MERCK & CO., INC. CIK: 310158 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0000310158-18-000011`
Period End Date	20180331
Filing Date	20180508
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	mrk-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 30 Cash Flow Statement 58 Comprehensive Income 14

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$205.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$210.00M	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$1.14B	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$1.19B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.09B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.48B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.60B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.48B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.86B	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.41B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $205 in 2018 and $210 in 2017)	`AccountsReceivableNetCurrent`	$7.25B	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $205 in 2018 and $210 in 2017)	`AccountsReceivableNetCurrent`	$6.87B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Inventories (excludes inventories of $1,136 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)	`InventoryNet`	$5.10B	USD	Point-in-time
Inventories (excludes inventories of $1,136 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)	`InventoryNet`	$5.38B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Treasury stock, shares (shares)	`TreasuryStockShares`	884.62M	shares	Point-in-time
Treasury stock, shares (shares)	`TreasuryStockShares`	880.49M	shares	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$4.11B	USD	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$4.30B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.09B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.77B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$11.03B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$12.12B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,483 in 2018 and $16,602 in 2017	`PropertyPlantAndEquipmentNet`	$12.56B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,483 in 2018 and $16,602 in 2017	`PropertyPlantAndEquipmentNet`	$12.44B	USD	Point-in-time
Goodwill	`Goodwill`	$18.28B	USD	Point-in-time
Goodwill	`Goodwill`	$18.30B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$14.18B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$13.50B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$6.56B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$6.08B	USD	Point-in-time
Total Assets	`Assets`	$87.87B	USD	Point-in-time
Total Assets	`Assets`	$86.04B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$3.06B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$2.06B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$3.10B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$3.16B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$9.71B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$10.43B	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$708.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$717.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.32B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.32B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.96B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.61B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$21.35B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$21.50B	USD	Point-in-time
Deferred Income Taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.21B	USD	Point-in-time
Deferred Income Taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.22B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$11.12B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$11.47B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017	`CommonStockValue`	$1.79B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017	`CommonStockValue`	$1.79B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$39.87B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$39.90B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$41.11B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$41.35B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.91B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.06B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$77.71B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$78.13B	USD	Point-in-time
Less treasury stock, at cost: 884,622,139 shares in 2018 and 880,491,914 shares in 2017	`TreasuryStockValue`	$43.79B	USD	Point-in-time
Less treasury stock, at cost: 884,622,139 shares in 2018 and 880,491,914 shares in 2017	`TreasuryStockValue`	$44.04B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$34.34B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$33.67B	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$233.00M	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$233.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$33.90B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$34.57B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$40.31B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$40.09B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$87.87B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$86.04B	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
Sales	`SalesRevenueGoodsNet`	$9.43B	USD	1 Quarter
Sales	`SalesRevenueGoodsNet`	$10.04B	USD	1 Quarter
Materials and production	`CostOfGoodsSold`	$3.18B	USD	1 Quarter
Materials and production	`CostOfGoodsSold`	$3.05B	USD	1 Quarter
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$2.51B	USD	1 Quarter
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$2.47B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.83B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.20B	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$151.00M	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$95.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$291.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$71.00M	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$7.43B	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$8.69B	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.00B	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.34B	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$447.00M	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$604.00M	USD	1 Quarter
Net Income	`ProfitLoss`	$1.56B	USD	1 Quarter
Net Income	`ProfitLoss`	$741.00M	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.55B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$736.00M	USD	1 Quarter
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.56	USD	1 Quarter
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.27	USD	1 Quarter
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.27	USD	1 Quarter
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.56	USD	1 Quarter
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.48	USD	1 Quarter
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.47	USD	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCashAndCashEquivalents`	$4.00M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$3.00M	USD	Point-in-time
Net income	`ProfitLoss`	$1.56B	USD	1 Quarter
Net income	`ProfitLoss`	$741.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.19B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.14B	USD	1 Quarter
Intangible asset impairment charges	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$80.00M	USD	1 Quarter
Intangible asset impairment charges	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Charge for future payments related to Eisai collaboration license options	`ChargeForLicenseOptionsRelatedToCollaboration`	$650.00M	USD	1 Quarter
Charge for future payments related to Eisai collaboration license options	`ChargeForLicenseOptionsRelatedToCollaboration`	-	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-30.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-54.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$74.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$80.00M	USD	1 Quarter
Other	`OtherNoncashIncomeExpense`	$-50.00M	USD	1 Quarter
Other	`OtherNoncashIncomeExpense`	$28.00M	USD	1 Quarter
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$2.54B	USD	1 Quarter
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$1.47B	USD	1 Quarter
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$1.16B	USD	1 Quarter
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$286.00M	USD	1 Quarter
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$450.00M	USD	1 Quarter
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$339.00M	USD	1 Quarter
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$1.33B	USD	1 Quarter
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$2.93B	USD	1 Quarter
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.85B	USD	1 Quarter
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$6.82B	USD	1 Quarter
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$306.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$52.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$269.00M	USD	1 Quarter
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$3.19B	USD	1 Quarter
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-197.00M	USD	1 Quarter
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.00M	USD	1 Quarter
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$3.78B	USD	1 Quarter
Payments on debt	`RepaymentsOfLongTermDebt`	$1.00B	USD	1 Quarter
Payments on debt	`RepaymentsOfLongTermDebt`	$300.00M	USD	1 Quarter
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$566.00M	USD	1 Quarter
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.02B	USD	1 Quarter
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$1.29B	USD	1 Quarter
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$1.30B	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$313.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$230.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-83.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-23.00M	USD	1 Quarter
Net Cash (Used in) Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.72B	USD	1 Quarter
Net Cash (Used in) Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.46B	USD	1 Quarter
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$154.00M	USD	1 Quarter
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$253.00M	USD	1 Quarter
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.61B	USD	1 Quarter
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.19B	USD	1 Quarter
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.51B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.71B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.10B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.49B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.51B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.71B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.10B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.49B	USD	Point-in-time

Comprehensive Income 14 line items

Line Item	Tag	Value	Unit	Period
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.55B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$736.00M	USD	1 Quarter
Net unrealized loss on derivatives, net of reclassifications	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$-232.00M	USD	1 Quarter
Net unrealized loss on derivatives, net of reclassifications	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$-70.00M	USD	1 Quarter
Net unrealized (loss) gain on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$43.00M	USD	1 Quarter
Net unrealized (loss) gain on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-99.00M	USD	1 Quarter
Benefit plan net gain (loss) and prior service credit (cost), net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-36.00M	USD	1 Quarter
Benefit plan net gain (loss) and prior service credit (cost), net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-26.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$257.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$309.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$146.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$124.00M	USD	1 Quarter
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$860.00M	USD	1 Quarter
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$1.70B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.